your thoughts are interesting. I guess I have patience.
This is the bottom floor here. This is the time to pick up shares in the company and support an idea/product/concept with someone who obviously has passion to get it done.
An average of .0001 or .0002 should pay off nicely when this is .0008-.001 next quarter. How do we get that high?
We have a couple of hundred million share days
We get a few more people looking
We get a few people wanting to invest a few thousand dollars
We get ONE contract from the military, clinic, or overseas
This company needs visibility. It wouldn't surprise me if Steve is working overtime on doing those things that will give him visibility within the medical community, more within the military, and more overseas.
One thing that I do know, is that I did get a bit excited about his overseas comments. I started to think about the people who have a ton of money overseas. I started to think about those countries overseas that are a lot more willing to accept alternative medicine and adopt it fast and furious.
Could you imagine if he swung a deal to open 20 clinics in Germany with a large investor? Or how about some locations in Military bases overseas?
Get ONE rich sheik interested in this and he'll throw money at Steve to keep his harem healthy (okay, joke there).
In all seriousness, there are a bunch of you that have been here a while. If you need the money, I understand needing to sell. If you don't need the money and are just missing out on some opportunity cost, I think you should just let it ride and ...
I do think you should talk about Somatics to people. How is a company like this successful? Word of mouth, practitioners, etc.... Get them interested in the meidical benefits, have them look at what the possibilities are, and then if they want to get in on the ground floor, they might want to buy a few shares. They don't have to, but they should/could support the concept of somatics wherever they are because it does seem to heal people very nicely.
Thanks, love the great conversation here.